Clearstead Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $572K | Buy |
5,161
+2,175
| +73% | +$241K | 0.01% | 575 |
|
2025
Q1 | $335K | Buy |
2,986
+292
| +11% | +$32.7K | 0.01% | 676 |
|
2024
Q4 | $249K | Sell |
2,694
-428
| -14% | -$39.5K | ﹤0.01% | 785 |
|
2024
Q3 | $262K | Sell |
3,122
-85
| -3% | -$7.13K | ﹤0.01% | 766 |
|
2024
Q2 | $220K | Buy |
3,207
+5
| +0.2% | +$343 | ﹤0.01% | 794 |
|
2024
Q1 | $216K | Sell |
3,202
-57
| -2% | -$3.85K | 0.01% | 453 |
|
2023
Q4 | $264K | Sell |
3,259
-3,335
| -51% | -$270K | 0.01% | 420 |
|
2023
Q3 | $494K | Buy |
6,594
+3,816
| +137% | +$286K | 0.01% | 412 |
|
2023
Q2 | $214K | Sell |
2,778
-101
| -4% | -$7.78K | 0.01% | 421 |
|
2023
Q1 | $239K | Buy |
2,879
+476
| +20% | +$39.5K | 0.02% | 369 |
|
2022
Q4 | $206K | Sell |
2,403
-374
| -13% | -$32.1K | 0.02% | 375 |
|
2022
Q3 | $171K | Buy |
2,777
+487
| +21% | +$30K | 0.02% | 382 |
|
2022
Q2 | $142K | Buy |
2,290
+135
| +6% | +$8.37K | 0.01% | 429 |
|
2022
Q1 | $128K | Buy |
2,155
+1,085
| +101% | +$64.4K | 0.01% | 497 |
|
2021
Q4 | $78K | Sell |
1,070
-5,576
| -84% | -$406K | 0.01% | 576 |
|
2021
Q3 | $464K | Buy |
6,646
+196
| +3% | +$13.7K | 0.03% | 248 |
|
2021
Q2 | $444K | Buy |
6,450
+131
| +2% | +$9.02K | 0.03% | 242 |
|
2021
Q1 | $408K | Sell |
6,319
-406
| -6% | -$26.2K | 0.03% | 241 |
|
2020
Q4 | $392K | Buy |
6,725
+526
| +8% | +$30.7K | 0.04% | 228 |
|
2020
Q3 | $392K | Sell |
6,199
-312
| -5% | -$19.7K | 0.04% | 210 |
|
2020
Q2 | $501K | Buy |
6,511
+5,631
| +640% | +$433K | 0.06% | 174 |
|
2020
Q1 | $66K | Buy |
+880
| New | +$66K | 0.01% | 370 |
|
2017
Q3 | – | Sell |
-3,455
| Closed | -$245K | – | 252 |
|
2017
Q2 | $245K | Sell |
3,455
-965
| -22% | -$68.4K | 0.04% | 208 |
|
2017
Q1 | $300K | Buy |
4,420
+833
| +23% | +$56.5K | 0.04% | 178 |
|
2016
Q4 | $257K | Buy |
+3,587
| New | +$257K | 0.04% | 181 |
|